Advanced therapies emerge from advanced science — and must overcome the operational complexity inherent in their patient-centric paradigm when they...

Genentech, Takeda, Adaptimmune and other industry leaders join Vineti to form the core of this strategic collaboration. The group is...

Today, Vineti released an announcement about new industry collaboration around our proposal for a new patient ID for cell and gene therapies....